Over 15 years of marketing experience, has held senior marketing leadership roles at companies including General Mills and Novartis Consumer. Formerly the Head of Marketing for the Mike’s Beverage Company, a Division of Labatt Breweries.
20 years of experience as a business leader, most recently as CEO of international specialty pharmaceutical company Merus Labs. Previously served as CEO of both Teva Canada and Taro Canada, VP Marketing at Eli Lilly Canada and past Chair of the Canadian Generic Manufacturers Association.
Creative capital markets expert with deep experience M&A and take-public transactions
An initial team member at ABcann with over 15 years experience in various key leadership roles in business operations and finance. Strong knowledge of production operations, process improvement and operational efficiency.
Dr. Michael Bumby
20 years of experience in pharmaceuticals, previously CFO of three publicly held Canadian companies - most recently as CFO of Merus Labs. Key roles at Eli Lilly, including leading international BD activities for early and late stage assets at the Global Headquarters, and serving as regional CFO in Prague.
Over 20 years of legal experience starting at Stikeman Elliott and then managing his own practice. Andrew has been involved with ABcann since its inception, drafting and submitting the initial Health Canada license application
Over 10 years of experience as an entrepreneur, lawyer, and design thinker. Most recently as CEO of Harvest Medicine, led the company to become one of the fastest growing, highest rated, cannabis clinics in the country attractive over 12,000 patients in under a year.
Successful investor, Dragon on Dragon’s Den, Order of Canada recipient.
Former Member of Parliament, Municipal Counsellor, and successful entrepreneur
Corporate finance and M&A Advisor – experiences ranging from start-ups to Canada’s largest public companies
Former CEO of Glaxo Canada with significant board experience in for-profit & non-profit sectors
Raphael Mechoulam, PhD
The world-renowned cannabis scientist that discovered tetrahydrocannabinol (THC) and cannabidiol (CBD).
Donald I. Abrams, MD
Co-Author of The Chapter Cannabinoids and Cancer in the Oxford University Press.
Mike Dixon, PhD
Leading plant scientist – specializing in controlled environmental systems.
Chris Hudalla, PhD
Recognized Leader in analytical chemistry and method development.
Michael E. Shannon, M.A., M.Sc., M.D.
Accomplished Medical Advisor and Former Deputy Surgeon General for Canada.
Paul Daeninck, MD
Medical Oncologist and Palliative Medicine Consultant with Cancer Care Manitoba.
Mr. Richard Fitzgerald
Former CEO & Chairman of Diageo Canada – broad leadership experience in alcohol and tobacco industries